AI Terminal
ECO ANIMAL HEALTH GROUP PLC
Remuneration Information • Sep 27, 2021
7612_dirs_2021-09-27_ed2ac68b-3217-4ede-9f7f-80943b1ea6e4.html
Remuneration Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0798N
Eco Animal Health Group PLC
27 September 2021
27 September 2021
ECO Animal Health Group PLC
("ECO" or "the Company")
Deferred Share Awards to Executive Directors
ECO Animal Health Group plc announces that on 24 September 2021, deferred nominal cost share awards over 37,755 ordinary shares in the Company (representing approximately 0.05 percent of the Company's issued share capital) were granted in accordance with the rules of Company's Deferred Bonus Plan ("DBS") to the Executive Directors listed below. The awards represent 33% of the aggregate bonus awards earned by these Directors in respect of the Company's financial year ended 31 March 2021. Subject to the terms and conditions of the DBS, the deferred share awards may vest after a 3 year vesting period.
| Director | Position | Number of Deferred Share Awarded |
| Marc Loomes | Chief Executive Officer | 22,973 |
| Christopher Wilks | Chief Financial Officer | 14,782 |
As indicated in the Circular to shareholders dated 4 February 2021 the DBS has been established to allow the Remuneration Committee to require a significant part of the annual bonuses awarded to Executive Directors to be deferred in exchange for nominal cost share awards.
For further information please contact:
| ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO) |
020 8447 8899 |
| IFC Advisory Graham Herring Zach Cohen |
020 3934 6630 |
| Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas |
020 7496 3000 |
| Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden |
020 7418 8900 |
PDMR Notification - ECO LTIP Nominal Cost Conditional Share Awards
1.
Details of the person discharging managerial responsibilities / person closely associated
a.
Name
1. Marc Loomes
2. Chris Wilks
2.
Reason for the notification
a.
Position/status
1. Chief Executive Officer
2. Chief Financial Officer
b.
Initial notification
/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Eco Animal Health Group Plc
b.
LEI
2138009XN9DJ3YP70B55
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 5p each.
GB0032036807
b.
Nature of the transaction
Award of deferred nominal cost share awards in accordance with the Company's DBS. These shares may vest after a 3 year vesting period subject to the rules of the DBS.
c.
Price(s) and volume(s)
Numbers 1 to 2 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
| Price(s) | Volume(s) |
| 1. 5p | 22,973 |
| 2. 5p | 14,782 |
d.
Aggregated information
Aggregated volume
Price
n/a
e.
Date of the transaction
24 September 2021
f.
Place of the transaction
Outside a trading venue.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBBGDCSGDDGBR